Page 38 - Read Online

Donskov et al. J Transl Genet Genom 2021;5:136-62 https://dx.doi.org/10.20517/jtgg.2021.12 Page 23

37. O'Sullivan SE. An update on PPAR activation by cannabinoids. Br J Pharmacol 2016;173:1899-910. DOI PubMed PMC
38. Lev-Ran S, Roerecke M, Le Foll B, George TP, McKenzie K, Rehm J. The association between cannabis use and depression: a
systematic review and meta-analysis of longitudinal studies. Psychol Med 2014;44:797-810. DOI PubMed
39. Berger M, Nelson B, Markulev C, et al. Relationship between polyunsaturated fatty acids and psychopathology in the NEURAPRO
clinical trial. Front Psychiatry 2019;10:393. DOI PubMed PMC
40. Amminger GP, McGorry PD. Update on ω-3 polyunsaturated fatty acids in early-stage psychotic disorders.
Neuropsychopharmacology 2012;37:309-10. DOI PubMed PMC
41. Olivares AM, Moreno-Ramos OA, Haider NB. Role of nuclear receptors in central nervous system development and associated
diseases. J Exp Neurosci 2015;9:93-121. DOI PubMed PMC
42. Ferrara SJ, Scanlan TS. A CNS-targeting prodrug strategy for nuclear receptor modulators. J Med Chem 2020;63:9742-51. DOI
PubMed
43. Mackeh R, Marr AK, Dargham SR, Syed N, Fakhro KA, Kino T. Single-nucleotide variations of the human nuclear hormone receptor
genes in 60,000 individuals. J Endocr Soc 2018;2:77-90. DOI PubMed PMC
44. Achermann JC, Schwabe J, Fairall L, Chatterjee K. Genetic disorders of nuclear receptors. J Clin Invest 2017;127:1181-92. DOI
PubMed PMC
45. Guissart C, Latypova X, Rollier P, et al. Dual molecular effects of dominant RORA mutations cause two variants of syndromic
intellectual disability with either autism or cerebellar ataxia. Am J Hum Genet 2018;102:744-59. DOI PubMed PMC
46. Rudolf G, Lesca G, Mehrjouy MM, et al. Loss of function of the retinoid-related nuclear receptor (RORB) gene and epilepsy. Eur J
Hum Genet 2016;24:1761-70. DOI PubMed PMC
47. Millard CJ, Watson PJ, Fairall L, Schwabe JW. An evolving understanding of nuclear receptor coregulator proteins. J Mol
Endocrinol 2013;51:T23-36. DOI PubMed PMC
48. Malovannaya A, Lanz RB, Jung SY, et al. Analysis of the human endogenous coregulator complexome. Cell 2011;145:787-99. DOI
PubMed PMC
49. Broekema MF, Hollman DAA, Koppen A, et al. Profiling of 3696 nuclear receptor-coregulator interactions: a resource for biological
and clinical discovery. Endocrinology 2018;159:2397-407. DOI PubMed
50. Tagami T, Madison LD, Nagaya T, Jameson JL. Nuclear receptor corepressors activate rather than suppress basal transcription of
genes that are negatively regulated by thyroid hormone. Mol Cell Biol 1997;17:2642-8. DOI PubMed PMC
51. Berghagen H, Ragnhildstveit E, Krogsrud K, Thuestad G, Apriletti J, Saatcioglu F. Corepressor SMRT functions as a coactivator for
thyroid hormone receptor T3Ralpha from a negative hormone response element. J Biol Chem 2002;277:49517-22. DOI PubMed
52. Tora L, Gronemeyer H, Turcotte B, Gaub MP, Chambon P. The N-terminal region of the chicken progesterone receptor specifies
target gene activation. Nature 1988;333:185-8. DOI PubMed
53. Shao D, Lazar MA. Modulating nuclear receptor function: may the phos be with you. J Clin Invest 1999;103:1617-8. DOI PubMed
PMC
54. Lonard DM, Lanz RB, O'Malley BW. Nuclear receptor coregulators and human disease. Endocr Rev 2007;28:575-87. DOI PubMed
55. Kong Y, Zhou W, Sun Z. Nuclear receptor corepressors in intellectual disability and autism. Mol Psychiatry 2020;25:2220-36. DOI
PubMed PMC
56. Tabet AC, Leroy C, Dupont C, et al. De novo deletion of TBL1XR1 in a child with non-specific developmental delay supports its
implication in intellectual disability. Am J Med Genet A 2014;164A:2335-7. DOI PubMed
57. Vaqueiro AC, de Oliveira CP, Cordoba MS, et al. Expanding the spectrum of TBL1XR1 deletion: report of a patient with brain and
cardiac malformations. Eur J Med Genet 2018;61:29-33. DOI PubMed
58. Sakaguchi Y, Uehara T, Suzuki H, et al. Haploinsufficiency of NCOR1 associated with autism spectrum disorder, scoliosis, and
abnormal palatogenesis. Am J Med Genet A 2018;176:2466-9. DOI PubMed
59. Zhou W, He Y, Rehman AU, et al; DDD study. Author correction: loss of function of NCOR1 and NCOR2 impairs memory through
a novel GABAergic hypothalamus-CA3 projection. Nat Neurosci 2019;22:1533. DOI PubMed
60. Sajan SA, Jhangiani SN, Muzny DM, et al. Enrichment of mutations in chromatin regulators in people with Rett syndrome lacking
mutations in MECP2. Genet Med 2017;19:13-9. DOI PubMed PMC
61. Reay WR, Atkins JR, Quidé Y, Carr VJ, Green MJ, Cairns MJ. Polygenic disruption of retinoid signalling in schizophrenia and a
severe cognitive deficit subtype. Mol Psychiatry 2020;25:719-31. DOI PubMed PMC
62. Viosca J, Lopez-Atalaya JP, Olivares R, Eckner R, Barco A. Syndromic features and mild cognitive impairment in mice with genetic
reduction on p300 activity: differential contribution of p300 and CBP to Rubinstein-Taybi syndrome etiology. Neurobiol Dis
2010;37:186-94. DOI PubMed
63. Qvist P, Christensen JH, Vardya I, et al. The schizophrenia-associated BRD1 gene regulates behavior, neurotransmission, and
expression of schizophrenia risk enriched gene sets in mice. Biol Psychiatry 2017;82:62-76. DOI PubMed
64. Rajkumar AP, Qvist P, Donskov JG, et al. Reduced Brd1 expression leads to reversible depression-like behaviors and gene-
expression changes in female mice. Transl Psychiatry 2020;10:239. DOI PubMed PMC
65. Qvist P, Eskildsen SF, Hansen B, et al. Brain volumetric alterations accompanied with loss of striatal medium-sized spiny neurons
+/-
and cortical parvalbumin expressing interneurons in Brd1 mice. Sci Rep 2018;8:16486. DOI PubMed PMC
66. Oliveira AM, Estévez MA, Hawk JD, Grimes S, Brindle PK, Abel T. Subregion-specific p300 conditional knock-out mice exhibit
long-term memory impairments. Learn Mem 2011;18:161-9. DOI PubMed PMC
67. Valor LM, Pulopulos MM, Jimenez-Minchan M, Olivares R, Lutz B, Barco A. Ablation of CBP in forebrain principal neurons causes
modest memory and transcriptional defects and a dramatic reduction of histone acetylation but does not affect cell viability. J